CRISPR Screening: from design and discovery to validation

Gillian received a BSc in Biomedical Sciences, followed by a PhD in Cellular and Molecular Cancer Biology in the UK. She pursued five years of postdoctoral research in the USA and during this time co-authored 13 peer reviewed publications in the field of cancer biology, with a focus on gene regulation. Gillian spent her most recent years enabling other scientists and colleagues with her work at companies. Today, she serves as a global strategic scientific and business partner to the commercial teams as well as to our gene editing clients around the world, ensuring the client is at the core of all we do.